Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018		Mar. 31, 2017
Revenues
Collaboration and licensing revenues, including $16,640 and $28,887 from related parties during the three months ended March 31, 2018 and 2017, respectively	$ 19,848	[1]	$ 33,065
Product revenues	7,152		8,130
Service revenues	12,247		12,031
Other revenues	419		521
Total revenues	39,666		53,747
Operating Expenses
Cost of products	8,530		9,006
Cost of services	6,783		6,804
Research and development	37,267		34,180
Selling, general and administrative	39,737		35,138
Total operating expenses	92,317		85,128
Operating loss	(52,651)		(31,381)
Other Income, Net
Unrealized depreciation in fair value of equity securities and preferred stock, net	(1,096)		(1,622)
Interest expense	(99)		(179)
Interest and dividend income	5,470		4,624
Other income (expense), net	(659)		595
Total other income, net	3,616		3,418
Equity in net loss of affiliates	(2,460)		(4,947)
Loss before income taxes	(51,495)		(32,910)
Income tax benefit	4,086		533
Net loss	(47,409)		(32,377)
Net loss attributable to the noncontrolling interests	1,244		978
Net loss attributable to Intrexon	$ (46,165)		$ (31,399)
Net loss attributable to Intrexon per share, basic and diluted (in usd per share)	$ (0.36)		$ (0.26)
Weighted average shares outstanding, basic and diluted (in shares)	127,693,336		118,956,780

[1] Collaboration and licensing revenues from related parties, as previously reported, totaled $19,815. The effect of restatement caused a decrease of $3,175, resulting in collaboration and licensing revenues from related parties, as restated, totaling $16,640.